Eckert & Ziegler Strahlen- Und Medizintechnik AG (EUZ) | WebDisclosure

Basculer en Français

8313	Companies
115772	Keywords
55886	Articles
62789	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

PRESS RELEASE

published on 05/14/2024 at 07:50, 6 months 11 days ago

Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
Eckert & Ziegler SE reports strong Q1 results with 17% sales increase and 41% rise in adjusted EBIT. Forecast for 2024 confirmed. Read more: https://www.ezag.com/fileadmin/user_upload/ezag/investors-financial-reports/englisch/euz124e.pdf

Adjusted EBIT Sales Increase 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF

published on 04/22/2024 at 14:54, 7 months 3 days ago

Eckert & Ziegler : augmentation des ventes et des bénéfices au premier trimestre, prévisions 2024 inchangées

Prévisions 2024 Croissance De L'EBIT Eckert & Ziegler SE Résultats Financiers Du Premier Trimestre Augmentation Des Ventes
BRIEF

published on 04/22/2024 at 14:54, 7 months 3 days ago

Eckert & Ziegler: Boost in Q1 Sales and Earnings, 2024 Forecasts Unchanged

Sales Increase 2024 Forecast EBIT Growth Eckert & Ziegler SE Q1 Financial Results
PRESS RELEASE

published on 04/22/2024 at 14:49, 7 months 3 days ago

EQS-Adhoc: Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
Eckert & Ziegler SE reports strong Q1 results with sales of EUR 67.6 million and net income of EUR 8.5 million. 2024 annual forecast confirmed

Sales Earnings 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF

published on 03/22/2024 at 07:50, 8 months 3 days ago

Eckert & Ziegler poursuit sa croissance après un exercice 2023 réussi

Croissance Financière Résultats Annuels Eckert & Ziegler Exercice 2023 Produits Radiopharmaceutiques
BRIEF

published on 03/22/2024 at 07:50, 8 months 3 days ago

Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023

2023 Financial Year Eckert & Ziegler Annual Results Financial Growth Radiopharmaceuticals
PRESS RELEASE

published on 03/22/2024 at 07:45, 8 months 3 days ago

Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
Eckert & Ziegler SE reports sales growth in 2023 financial year, with sales reaching €246.1 million. Expecting sales of nearly €265 million in 2024

Sales Growth EBIT Financial Year 2023 Eckert & Ziegler SE Radiopharmaceuticals
BRIEF

published on 03/21/2024 at 10:05, 8 months 4 days ago

Eckert & Ziegler franchit une étape clé avec la certification MDR pour les graines de prostate

Eckert & Ziegler Sécurité Du Patient Certification MDR Graines De Prostate Curiethérapie
BRIEF

published on 03/21/2024 at 10:05, 8 months 4 days ago

Eckert & Ziegler Achieves Key Milestone with MDR Certification for Prostate Seeds

Eckert & Ziegler Patient Safety MDR Certification Prostate Seeds Brachytherapy
PRESS RELEASE

published on 03/21/2024 at 10:00, 8 months 4 days ago

Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU

DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy

Accesswire

Published on 11/26/2024 at 00:37, 16 minutes ago

CORRECTION; CoTec Holdings Corp. Announces Convertible Loan Agreement
Published on 11/26/2024 at 00:20, 33 minutes ago

NexgenRx Announces Third Quarter Results and Declaration of Divdend
Published on 11/26/2024 at 00:00, 53 minutes ago

Medicure Reports Financial Results For Quarter Ended September 30, 2024
Published on 11/26/2024 at 00:00, 53 minutes ago

Justera Health Revises Vesting Schedule of RSU Grant
Published on 11/25/2024 at 23:20, 1 hour 33 minutes ago

Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment

View all ACCESSWIRE

EQS Group

Published on 11/25/2024 at 20:35, 4 hours 18 minutes ago

Launch of World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 to Advance the Country’s Shift Towards Next-Generation Industries and High-Value Manufacturing
Published on 11/25/2024 at 20:35, 4 hours 18 minutes ago

World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 : Le Maroc se positionne comme leader des industries de nouvelle génération
Published on 11/25/2024 at 20:34, 4 hours 18 minutes ago

Avolta wins new ten-year contract, adds Manaus Airport to Brazil portfolio
Published on 11/25/2024 at 19:00, 5 hours 53 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 18 NOVEMBRE 2024 au 22 NOVEMBRE 2024
Published on 11/25/2024 at 18:55, 5 hours 58 minutes ago

Molten Ventures Plc: HOL-Holding(s) in Company

Les Echos

Published on 11/25/2024 at 18:00, 6 hours 53 minutes ago

Chiffre d’affaires consolidé 2023-2024 : 91 M€ en repli de 9,4 %
Published on 11/25/2024 at 17:55, 6 hours 58 minutes ago

Déclaration des transactions sur actions propres réalisées du 18/11/2024 au 22/11/2024
Published on 11/25/2024 at 17:55, 6 hours 58 minutes ago

Disclosure of trading in own shares from 18/11/2024 to 22/11/2024
Published on 11/25/2024 at 17:45, 7 hours 7 minutes ago

Reporting on share buyback transactions carried out between November 19 and November 22, 2024
Published on 11/25/2024 at 17:45, 7 hours 7 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 19 et le 22 novembre 2024

View all LES ECHOS COMFI WIRE